Announcements
- Nyxoah Présente ses Résultats Financiers et Opérationnels pour le Premier Trimestre 2024
- Nyxoah Reports First Quarter 2024 Financial and Operating Results
- Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024
- Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2024 le 14 Mai 2024
- Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 12 juin 2024
- Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 12, 2024
- Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer
- Nyxoah Nomme le Dr Maurits S. Boon, MD, au Poste de Chief Medical Officer
- Informations sur le nombre total de droits de vote et d'actions
- Information on the total number of voting rights and shares
More ▼
Key statistics
On Wednesday, Nyxoah SA (5YI:FRA) closed at 10.70, -39.55% below its 52-week high of 17.70, set on Mar 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | 9.06 |
Offer | 10.00 |
Previous close | 10.70 |
Average volume | 134.22 |
---|---|
Shares outstanding | 28.66m |
Free float | 14.55m |
P/E (TTM) | -- |
Market cap | 276.30m EUR |
EPS (TTM) | -1.55 EUR |
Data delayed at least 15 minutes, as of May 15 2024.
More ▼